Journal
CELL DEATH & DISEASE
Volume 12, Issue 12, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/s41419-021-04404-1
Keywords
-
Categories
Funding
- Municipio de Loule
- Portuguese Science and Technology Foundation (FCT) [ALG-01-0145-FEDER-29480]
- CRESC ALGARVE 2020
- French Muscular Dystrophy Association (AFM-Telethon) project [22424]
- Ataxia UK (ZUNIALGA project)
- FCT [SFRH/BD/133192/2017]
- [FCT: PPBI-POCI-01-0145-FEDER-022122]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/133192/2017] Funding Source: FCT
Ask authors/readers for more resources
Spinocerebellar ataxia type 2 (SCA2) is an incurable genetic neurodegenerative disorder characterized by progressive degeneration of brain regions. Mutations in the ATXN2 gene lead to toxic polyglutamine segment in ataxin-2 protein. This study suggests autophagy plays a crucial role in SCA2 pathology and targeting this pathway could be a potential treatment strategy.
Spinocerebellar ataxia type 2 (SCA2) is an incurable and genetic neurodegenerative disorder. The disease is characterized by progressive degeneration of several brain regions, resulting in severe motor and non-motor clinical manifestations. The mutation causing SCA2 disease is an abnormal expansion of CAG trinucleotide repeats in the ATXN2 gene, leading to a toxic expanded polyglutamine segment in the translated ataxin-2 protein. While the genetic cause is well established, the exact mechanisms behind neuronal death induced by mutant ataxin-2 are not yet completely understood. Thus, the goal of this study is to investigate the role of autophagy in SCA2 pathogenesis and investigate its suitability as a target for therapeutic intervention. For that, we developed and characterized a new striatal lentiviral mouse model that resembled several neuropathological hallmarks observed in SCA2 disease, including formation of aggregates, neuronal marker loss, cell death and neuroinflammation. In this new model, we analyzed autophagic markers, which were also analyzed in a SCA2 cellular model and in human post-mortem brain samples. Our results showed altered levels of SQSTM1 and LC3B in cells and tissues expressing mutant ataxin-2. Moreover, an abnormal accumulation of these markers was detected in SCA2 patients' striatum and cerebellum. Importantly, the molecular activation of autophagy, using the compound cordycepin, mitigated the phenotypic alterations observed in disease models. Overall, our study suggests an important role for autophagy in the context of SCA2 pathology, proposing that targeting this pathway could be a potential target to treat SCA2 patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available